On March 29, 2023 Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, reported that management will present and participate in the following investor conferences (Press release, Tyra Biosciences, MAR 29, 2023, View Source [SID1234629521]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Cantor’s The Future of Oncology Virtual Symposium
Todd Harris, CEO of TYRA, will participate virtually in a fireside chat on Tuesday, April 4, 2023, at 2:15 pm ET
Bank of America 2023 Healthcare Conference
Mr. Harris will present on Thursday, May 11, 2023, at 9:35 am PT
A live and archived webcast of the Bank of America event will be available via the For Investors page on the Investor section of the TYRA website.